Skip to main content

States must now ensure availability of the Sputnik precautionary dose at private COVID-19 vaccination centers

States must now ensure availability of the Sputnik precautionary dose at private COVID-19 vaccination centers

The Union Department of Health, in its communication to stakeholders on Thursday, said that while the COVID-19 pandemic continues to pose challenges, it is essential that states remain aware, alert and prepared to deal with other public health threats such as Monkeypox which is on the rise worldwide.

He also added that taking the precautionary dose of Sputnik V is only 0.5% of those due for it. He has now advised states to ensure the availability of the Sputnik precautionary dose at private COVID-19 vaccination centers. They are also advised to reach out to recipients to take the precautionary dose

monkeypox awareness

In his letters to stakeholders, Health Secretary Rajesh Bhushan said states must ensure screening and testing of all suspected Monkeypox cases at points of entry and in the community as part of preparedness. of India against the disease.

States and Union Territories are also required to identify hospitals and ensure adequate human resources and logistical support to handle any suspected or confirmed cases of Monkeypox.

The World Health Organization (WHO) reported that from January 1 to June 22, a total of 3,413 laboratory-confirmed monkeypox cases and one death were reported to it from 50 countries and territories.

A majority of these cases were reported in the European region (86%) and the Americas (11%).

“As this is the first time that cases and clusters have been reported simultaneously across five WHO regions, the global health body has assessed the overall risk of case spread as ‘globally moderate’. The continued expansion of Monkeypox disease globally also calls for proactive strengthening and operationalization of public health actions required for disease preparedness and response in India,” said Mr. Bhushan.

COVID-19 Challenge

He added that as the COVID-19 pandemic continues to pose challenges, it is critical that we remain aware of and alert to other public health threats and proactively prepare to address them.

Meanwhile, stating that the absorption of the precautionary dose of Sputnik-V is only 0.5% of those due to it, Mr. Bhushan said in his letter that to increase the absorption of the precautionary dose of Sputnik-V vaccine due by recipient states must ensure the availability of Sputnik V vaccine (Component I) and the functionality of private CVCs can be ensured.

The private CVCs, which provided the Sputnik-V vaccine, should contact the recipients due to receive the doses due (second dose and precautionary dose) and targeted communication can be established for the recipients due for the precautionary dose of Sputnik-V .

Read it guidelines for the management of monkeypox disease as questions by the Department of Health and Family Welfare here.